TY - JOUR
T1 - Monitoring of health-related quality of life and symptoms in prostate cancer survivors
T2 - A randomized trial
AU - Davis, Kimberly M.
AU - Dawson, David
AU - Kelly, Scott
AU - Red, Sara
AU - Penek, Sofiya
AU - Lynch, John
AU - Collins, Sean
AU - Lynch, Barlow
AU - Porrazzo, Michael
AU - Bass, Michael
AU - Taylor, Kathryn L.
N1 - Publisher Copyright:
© 2013 Frontline Medical Communications.
PY - 2013/12/1
Y1 - 2013/12/1
N2 - Background: Routine symptom and health-related quality of life (HRQOL) assessments can engage patients, give provider feedback, and improve doctor/patient communication. Objective: We compared the impact of a technology-assisted symptom monitoring system versus usual care on HRQOL and doctor/patient communication in early-stage prostate cancer (PCa) survivors. Methods: Men (N = 94) were on average 62-years old, mostly African American (AA; 61.7%), and 10-19 months post-treatment. They were randomized to symptom monitoring plus feedback (SM+F; n = 49) or usual care (UC; n = 45). SM+F participants completed a 12-item telephone-assisted monitoring intervention. All participants completed a baseline and 2 follow-up interviews. Results: Among the SM+F participants, perceptions of the monitoring system were positive: 97.1% endorsed it as easy/very easy to use and 85% felt all patients could benefit from it. At baseline, men reported favorable general and cancer-specific HRQOL and doctor/patient communication, but poorer urinary and sexual function. Although there was no overall impact of the intervention, post hoc exploratory analyses indicated that among AA men, those who received SM+F improved relative to UC on doctor/patient communication (P < .05), general HRQOL (P < .06), and sexual function (P < .05). Limitations: Variability in survivor follow-up care, limited access to eligible participants, and minimal physician training in the use of reports likely decreased physician investment. Conclusion: Overall, PCa survivors were receptive to this monitoring system. Exploratory analyses suggest that this technologyassisted monitoring system may be of particular benefit to African American men. Additional studies with larger samples, more intervention time-points, and increased physician training are needed to strengthen the intervention's impact.
AB - Background: Routine symptom and health-related quality of life (HRQOL) assessments can engage patients, give provider feedback, and improve doctor/patient communication. Objective: We compared the impact of a technology-assisted symptom monitoring system versus usual care on HRQOL and doctor/patient communication in early-stage prostate cancer (PCa) survivors. Methods: Men (N = 94) were on average 62-years old, mostly African American (AA; 61.7%), and 10-19 months post-treatment. They were randomized to symptom monitoring plus feedback (SM+F; n = 49) or usual care (UC; n = 45). SM+F participants completed a 12-item telephone-assisted monitoring intervention. All participants completed a baseline and 2 follow-up interviews. Results: Among the SM+F participants, perceptions of the monitoring system were positive: 97.1% endorsed it as easy/very easy to use and 85% felt all patients could benefit from it. At baseline, men reported favorable general and cancer-specific HRQOL and doctor/patient communication, but poorer urinary and sexual function. Although there was no overall impact of the intervention, post hoc exploratory analyses indicated that among AA men, those who received SM+F improved relative to UC on doctor/patient communication (P < .05), general HRQOL (P < .06), and sexual function (P < .05). Limitations: Variability in survivor follow-up care, limited access to eligible participants, and minimal physician training in the use of reports likely decreased physician investment. Conclusion: Overall, PCa survivors were receptive to this monitoring system. Exploratory analyses suggest that this technologyassisted monitoring system may be of particular benefit to African American men. Additional studies with larger samples, more intervention time-points, and increased physician training are needed to strengthen the intervention's impact.
UR - http://www.scopus.com/inward/record.url?scp=84897574985&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84897574985&partnerID=8YFLogxK
U2 - 10.12788/j.suponc.0013
DO - 10.12788/j.suponc.0013
M3 - Article
C2 - 24645337
AN - SCOPUS:84897574985
SN - 1544-6794
VL - 11
SP - 174
EP - 182
JO - Journal of Supportive Oncology
JF - Journal of Supportive Oncology
IS - 4
ER -